The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Sebastian Other-Gee Pohl one year into his EACR-Boehringer Ingelheim Postdoctoral Fellowship

July 25, 2024
Sebastian Other-Gee Pohl receives EACR-Boehringer Ingelheim Postdoctoral Fellowship
Sebastian Other-Gee Pohl has now completed his first year of his EACR-Boehringer Ingelheim Postdoctoral Fellowship, funding that is awarded for a period of up to three years to support excellent postdoctoral researchers in laboratories throughout Europe.

Sebastian is a Postdoctoral Research Fellow in the Colorectal Stem Cell Transformation Lab (Kevin Myant Lab) at the CRUK Scotland Centre, Institute of Genetics and Cancer (IGC), within the University of Edinburgh. We recently caught up with him to hear about the progress he has made in his research during this first year.

Can you tell us about the topic of the research you are undertaking during your fellowship?

Overall, my research involves investigating whether targeting a specific RNA splicing factor can switch immune-cold colorectal cancers (CRC) into immune-hot tumours. In doing so, I aim to determine whether this splicing factor is a therapeutic target, and likely to increase the efficacy of immune checkpoint blockade therapies, which have incredibly low effectiveness in the majority of CRCs. To do this we are using conditional degron tags in vitro and in vivo to better model therapeutic intervention.

At this stage, how do you think the fellowship will be beneficial to your research and your career?

This fellowship, and the on-going support that BI have shown has been crucial in allowing me to comprehensively investigate what I believe is a very important research problem. It has also been a great experience to interact with scientists from BI and receiving their feedback as this project progresses. At this stage of my career this fellowship may prove to be instrumental in allowing me to advance into more independent research roles.

What have been the highlights from the first year of your fellowship?

The highlight would definitely be attending my first EACR conference, which happened to be in Torino, Italy. I was fortunate enough to be able to present my fellowship plan, and some preliminary data. The conference also gave me the opportunity to meet and thank in person, people from Boehringer Ingelheim and the EACR who helped me following acceptance of the fellowship.

EACR Postdoctoral Fellowships

To find out more about the EACR’s other Postdoctoral Fellowships, click here.

Tags: EACR fundingpostdoctoral fellowships

Related Posts

Highlights in Cancer Research: September 2026

Highlights in Cancer Research: September 2026

September 9, 2026

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

VIDEO | Rapid and accurate pan-cancer subtyping using RNA-sequencing

VIDEO | Rapid and accurate pan-cancer subtyping using RNA-sequencing

July 23, 2026

Click above to watch On 20 July 2026, the EACR hosted a webinar in collaboration with Oxford Nanopore Technologies, one of our valued EACR Industry Partners....

Scientific Highlights from ‘Cancer Genomics, Multiomics and Computational Biology’ 2026

Scientific Highlights from ‘Cancer Genomics, Multiomics and Computational Biology’ 2026

July 15, 2026

The EACR's Cancer Genomics, Multiomics and Computational Biology conference (Essen, 12–14 May 2026) centred on integrating high-resolution genomic and multi-omic data with advanced computational and AI-driven...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

“Practical insights into leadership, communication, negotiation, and career development”: Inside the 2026 Women in Leadership Workshop
Career

“Practical insights into leadership, communication, negotiation, and career development”: Inside the 2026 Women in Leadership Workshop

September 11, 2026
Virtual conferences are no longer a compromise: What six years of data reveals
Community

Virtual conferences are no longer a compromise: What six years of data reveals

September 11, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR